How Many Cores Should be Obtained During Saturation Biopsy in the Era of Multiparametric Magnetic Resonance? Experience in 875 Patients Submitted to Repeat Prostate Biopsy
To evaluate the number of needle cores combined with multiparametric magnetic resonance imaging (mpMRI) findings needed to diagnose all clinically significant cases of prostate cancer (csPCa) in men subject to transperineal saturation biopsy (SPBx; 30 cores). From January 2016 to June 2019, 875 men...
Saved in:
| Published in | Urology (Ridgewood, N.J.) Vol. 137; pp. 133 - 137 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.03.2020
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | To evaluate the number of needle cores combined with multiparametric magnetic resonance imaging (mpMRI) findings needed to diagnose all clinically significant cases of prostate cancer (csPCa) in men subject to transperineal saturation biopsy (SPBx; 30 cores).
From January 2016 to June 2019, 875 men (median age 63 years) underwent repeat SPBx (median 30 cores) for the suspicion of cancer. All of the patients underwent for the first time 3.0 Tesla pelvic mpMRI before SPBx, and the lesions with Prostate Imaging-Reporting and Data System category ≥3 underwent additional transperineal-targeted fusion prostate biopsies (TPBx).
StageT1c PCa was found in 306/875 (34.5%), and 222/306 (72.5%) of them were classified as csPCa. SPBx missed 2/222 (1%) csPCa with International Society of Urologic Pathology Grade Group (GG) 3. TBPx missed 33/222 (14.9%) csPCa (21 vs 12 cases were GG1 vs GG3). The initial 20 needle SPBx cores obtained from the peripheric (16 cores) and anterior gland (4 cores) diagnosed all of the 222 (100%) csPCa only missing 84/129 (65.1%) indolent PCa thus presenting diagnostic accuracy, sensitivity, and specificity equal to 83.1%, 100%, and 65.1%, respectively.
In men subject to mpMRI and/or TPBx, a maximum of 20 systematic transperineal needle cores detected all cases of csPCa and minimized the diagnosis of indolent cancers. |
|---|---|
| AbstractList | To evaluate the number of needle cores combined with multiparametric magnetic resonance imaging (mpMRI) findings needed to diagnose all clinically significant cases of prostate cancer (csPCa) in men subject to transperineal saturation biopsy (SPBx; 30 cores).
From January 2016 to June 2019, 875 men (median age 63 years) underwent repeat SPBx (median 30 cores) for the suspicion of cancer. All of the patients underwent for the first time 3.0 Tesla pelvic mpMRI before SPBx, and the lesions with Prostate Imaging-Reporting and Data System category ≥3 underwent additional transperineal-targeted fusion prostate biopsies (TPBx).
StageT1c PCa was found in 306/875 (34.5%), and 222/306 (72.5%) of them were classified as csPCa. SPBx missed 2/222 (1%) csPCa with International Society of Urologic Pathology Grade Group (GG) 3. TBPx missed 33/222 (14.9%) csPCa (21 vs 12 cases were GG1 vs GG3). The initial 20 needle SPBx cores obtained from the peripheric (16 cores) and anterior gland (4 cores) diagnosed all of the 222 (100%) csPCa only missing 84/129 (65.1%) indolent PCa thus presenting diagnostic accuracy, sensitivity, and specificity equal to 83.1%, 100%, and 65.1%, respectively.
In men subject to mpMRI and/or TPBx, a maximum of 20 systematic transperineal needle cores detected all cases of csPCa and minimized the diagnosis of indolent cancers. To evaluate the number of needle cores combined with multiparametric magnetic resonance imaging (mpMRI) findings needed to diagnose all clinically significant cases of prostate cancer (csPCa) in men subject to transperineal saturation biopsy (SPBx; 30 cores).OBJECTIVETo evaluate the number of needle cores combined with multiparametric magnetic resonance imaging (mpMRI) findings needed to diagnose all clinically significant cases of prostate cancer (csPCa) in men subject to transperineal saturation biopsy (SPBx; 30 cores).From January 2016 to June 2019, 875 men (median age 63 years) underwent repeat SPBx (median 30 cores) for the suspicion of cancer. All of the patients underwent for the first time 3.0 Tesla pelvic mpMRI before SPBx, and the lesions with Prostate Imaging-Reporting and Data System category ≥3 underwent additional transperineal-targeted fusion prostate biopsies (TPBx).METHODSFrom January 2016 to June 2019, 875 men (median age 63 years) underwent repeat SPBx (median 30 cores) for the suspicion of cancer. All of the patients underwent for the first time 3.0 Tesla pelvic mpMRI before SPBx, and the lesions with Prostate Imaging-Reporting and Data System category ≥3 underwent additional transperineal-targeted fusion prostate biopsies (TPBx).StageT1c PCa was found in 306/875 (34.5%), and 222/306 (72.5%) of them were classified as csPCa. SPBx missed 2/222 (1%) csPCa with International Society of Urologic Pathology Grade Group (GG) 3. TBPx missed 33/222 (14.9%) csPCa (21 vs 12 cases were GG1 vs GG3). The initial 20 needle SPBx cores obtained from the peripheric (16 cores) and anterior gland (4 cores) diagnosed all of the 222 (100%) csPCa only missing 84/129 (65.1%) indolent PCa thus presenting diagnostic accuracy, sensitivity, and specificity equal to 83.1%, 100%, and 65.1%, respectively.RESULTSStageT1c PCa was found in 306/875 (34.5%), and 222/306 (72.5%) of them were classified as csPCa. SPBx missed 2/222 (1%) csPCa with International Society of Urologic Pathology Grade Group (GG) 3. TBPx missed 33/222 (14.9%) csPCa (21 vs 12 cases were GG1 vs GG3). The initial 20 needle SPBx cores obtained from the peripheric (16 cores) and anterior gland (4 cores) diagnosed all of the 222 (100%) csPCa only missing 84/129 (65.1%) indolent PCa thus presenting diagnostic accuracy, sensitivity, and specificity equal to 83.1%, 100%, and 65.1%, respectively.In men subject to mpMRI and/or TPBx, a maximum of 20 systematic transperineal needle cores detected all cases of csPCa and minimized the diagnosis of indolent cancers.CONCLUSIONIn men subject to mpMRI and/or TPBx, a maximum of 20 systematic transperineal needle cores detected all cases of csPCa and minimized the diagnosis of indolent cancers. |
| Author | Pepe, Pietro Pennisi, Michele Fraggetta, Filippo |
| Author_xml | – sequence: 1 givenname: Pietro surname: Pepe fullname: Pepe, Pietro email: piepepe@hotmail.com organization: Urology Unit, Cannizzaro Hospital, Catania, Italy – sequence: 2 givenname: Michele surname: Pennisi fullname: Pennisi, Michele organization: Urology Unit, Cannizzaro Hospital, Catania, Italy – sequence: 3 givenname: Filippo surname: Fraggetta fullname: Fraggetta, Filippo organization: Pathology Unit, Cannizzaro Hospital, Catania, Italy |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31758981$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkc9uEzEQxi1URNPCI4B85JJg7z-vhRAqIVCkVq0onK1Z72zqsLEX20u7z8RL4jTphUtPHo2-33zjb07IkXUWCXnN2YIzXr3bLEbvereeFhnjcsH5InWfkRkvMzGXUpZHZMaYZPMik-UxOQlhwxirqkq8IMc5F2Utaz4jf8_dHb0EO9Gl8xjoza0b-5Y2SK-aCMZiSz-P3tg1vYE4eojGWfrJuCFM1Fgab5GuPFDX0cuxj2YAD1uM3ug0dG0xpuI7BmfBavxIV_cDeoOp3sG1KOl1mog2JuOx2ZoYk190CRkQIr32LkSIeDB8SZ530Ad8dXhPyc8vqx_L8_nF1ddvy7OLuS64jPOyAKZboau21bLiIgdeipyhrJs6a0uBeQfQNa1gRQsAQhcNgzqvKmSyEprlp-Ttfu7g3e8RQ1RbEzT2PVh0Y1DZQ3xVXeRJ-uYgTetjqwZvtuAn9RhwErzfC3T6S_DYKW3iQ4rRg-kVZ2p3TrVRh3Oq3TkV5yp1E13-Rz8aPMV92HOYYvpj0CvdG2s09L9wUq0zT_D_AIbBvyo |
| CitedBy_id | crossref_primary_10_4081_aiua_2022_2_155 crossref_primary_10_4081_aiua_2022_2_166 crossref_primary_10_1016_j_urology_2020_07_068 crossref_primary_10_4081_aiua_2024_12358 crossref_primary_10_1186_s40644_022_00516_9 crossref_primary_10_3390_cancers15133329 crossref_primary_10_1186_s12894_024_01596_4 crossref_primary_10_4081_aiua_2022_3_270 crossref_primary_10_4081_aiua_2023_11322 crossref_primary_10_1016_j_clgc_2023_06_007 crossref_primary_10_3390_jcm11123473 crossref_primary_10_1002_cam4_7341 crossref_primary_10_1016_j_clgc_2021_01_004 crossref_primary_10_1016_j_clgc_2020_04_001 crossref_primary_10_1016_j_urology_2022_04_026 crossref_primary_10_32074_1591_951X_925 crossref_primary_10_1007_s00259_020_05058_5 crossref_primary_10_1016_j_euros_2022_01_001 crossref_primary_10_1016_j_urology_2023_04_013 crossref_primary_10_1186_s12894_022_01021_8 crossref_primary_10_4081_aiua_2022_3_274 crossref_primary_10_1002_pros_24585 crossref_primary_10_1186_s12894_024_01461_4 |
| Cites_doi | 10.1155/2016/3794738 10.1097/JU.0000000000000298 10.1016/j.juro.2016.06.079 10.1016/j.juro.2016.02.084 10.1016/j.juro.2018.06.033 10.1016/j.urology.2019.06.011 10.1111/bju.14017 10.1097/PAS.0000000000000530 10.1159/000358494 10.21873/anticanres.13254 10.1097/JU.0000000000000156 10.1016/j.clgc.2019.05.006 10.1007/s00345-019-02992-4 10.1016/j.purol.2017.10.001 10.1016/j.eururo.2013.03.030 10.1097/01.sla.0000133083.54934.ae 10.1016/j.juro.2018.02.067 10.1016/j.juro.2015.11.047 10.1016/j.clgc.2016.07.007 10.1016/j.eururo.2017.08.018 10.1038/s41391-018-0056-7 10.1016/j.euf.2019.06.015 10.1007/s00345-015-1749-3 10.1002/cncr.29874 10.1016/j.urology.2013.02.019 10.1016/j.ijrobp.2008.04.004 10.1016/j.juro.2018.04.061 10.1016/j.ejrad.2018.11.006 10.1016/j.urology.2007.07.068 |
| ContentType | Journal Article |
| Copyright | 2019 Elsevier Inc. Copyright © 2019 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2019 Elsevier Inc. – notice: Copyright © 2019 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.urology.2019.11.016 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1527-9995 |
| EndPage | 137 |
| ExternalDocumentID | 31758981 10_1016_j_urology_2019_11_016 S0090429519310222 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M -RU .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 3O- 4.4 457 4CK 4G. 53G 5RE 5VS 6PF 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAEJM AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABLJU ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJJEV AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEA HMK HMO HVGLF HZ~ IHE J1W KOM L7B LZ2 M29 M41 MO0 N9A O-L O9- OAUVE OK. OW. OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SPCBC SSH SSZ T5K UV1 WH7 WOW WUQ X7M XPP Z5R ZGI ~G- AAYXX AFCTW AGRNS CITATION RIG AACTN ACRZS AFKWA AJOXV AMFUW CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c419t-54a0cd7c6ddc96173a15730e98b82d57e3faafbd704daaa7c4b0a8366e0967c03 |
| ISSN | 0090-4295 1527-9995 |
| IngestDate | Thu Jul 10 22:10:53 EDT 2025 Wed Feb 19 02:31:20 EST 2025 Thu Apr 24 23:09:50 EDT 2025 Tue Jul 01 04:00:52 EDT 2025 Tue Aug 26 17:40:00 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | Copyright © 2019 Elsevier Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c419t-54a0cd7c6ddc96173a15730e98b82d57e3faafbd704daaa7c4b0a8366e0967c03 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 31758981 |
| PQID | 2317586843 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_2317586843 pubmed_primary_31758981 crossref_citationtrail_10_1016_j_urology_2019_11_016 crossref_primary_10_1016_j_urology_2019_11_016 elsevier_clinicalkey_doi_10_1016_j_urology_2019_11_016 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | March 2020 2020-03-00 2020-Mar 20200301 |
| PublicationDateYYYYMMDD | 2020-03-01 |
| PublicationDate_xml | – month: 03 year: 2020 text: March 2020 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Urology (Ridgewood, N.J.) |
| PublicationTitleAlternate | Urology |
| PublicationYear | 2020 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Pepe, Pennisi (bib0015) 2019; 39 Pepe, Aragona (bib0029) 2013; 81 Stefanova, Buckley, Flax (bib0028) 2019; 201 Pepe, Garufi, Priolo, Pennisi (bib0008) 2016; 34 Gorin, Meyer, Zimmerman (bib0004) 2019 Rosenkrantz, Verma, Choyke (bib0016) 2016; 196 Pepe, Aragona (bib0011) 2007; 70 Epstein, Egevad, Amin (bib0014) 2016; 40 Mols, Korfage, Vingerhoets (bib0023) 2009; 73 Tu, Liu, Chang (bib0030) 2019 Valerio, Anele, Bott (bib0002) 2016; 195 Preisser, Theissen, Wenzel (bib0007) 2019 Filson, Natarajan, Margolis (bib0005) 2016; 122 Altok, Kim, Patel (bib0006) 2018; 21 Mortezavi, Krauter, Gu (bib0025) 2019 1 Pepe, Garufi, Priolo, Galia, Fraggetta, Pennisi (bib0003) 2018; 200 Moore, Kasivisvanathan, Scott Eggener (bib0009) 2013; 64 (bib0001) 2015 Borkowetz, Hadaschik, Platzek (bib0020) 2018; 121 Recabal, Assel, Sjoberg (bib0017) 2016; 196 Gross, Alshak, Shoag (bib0022) 2019 Miah, Eldred-Evans, Simmons (bib0026) 2018; 200 Aminsharifi, Gupta, Tsivian, Sekar, Sze, Polascik (bib0027) 2019; 110 Pepe, Dibenedetto, Pennisi, Fraggetta, Colecchia, Aragona (bib0012) 2014; 93 Mortezavi, Märzendorfer, Donati (bib0019) 2018; 200 Dindo, Clavien (bib0013) 2004; 2 Ting, Van Leeuwen, Thompson (bib0024) 2016; 2016 Pepe, Garufi, Priolo, Pennisi (bib0010) 2017; 15 Albisinni, Aoun, Noel (bib0018) 2018; 28 Faria, Soares, Spackman (bib0021) 2018; 73 Pepe (10.1016/j.urology.2019.11.016_bib0010) 2017; 15 Pepe (10.1016/j.urology.2019.11.016_bib0008) 2016; 34 Dindo (10.1016/j.urology.2019.11.016_bib0013) 2004; 2 Altok (10.1016/j.urology.2019.11.016_bib0006) 2018; 21 Valerio (10.1016/j.urology.2019.11.016_bib0002) 2016; 195 Mols (10.1016/j.urology.2019.11.016_bib0023) 2009; 73 Miah (10.1016/j.urology.2019.11.016_bib0026) 2018; 200 Filson (10.1016/j.urology.2019.11.016_bib0005) 2016; 122 Mortezavi (10.1016/j.urology.2019.11.016_bib0025) 2019 Pepe (10.1016/j.urology.2019.11.016_bib0029) 2013; 81 Moore (10.1016/j.urology.2019.11.016_bib0009) 2013; 64 Recabal (10.1016/j.urology.2019.11.016_bib0017) 2016; 196 Ting (10.1016/j.urology.2019.11.016_bib0024) 2016; 2016 Rosenkrantz (10.1016/j.urology.2019.11.016_bib0016) 2016; 196 Stefanova (10.1016/j.urology.2019.11.016_bib0028) 2019; 201 Faria (10.1016/j.urology.2019.11.016_bib0021) 2018; 73 Pepe (10.1016/j.urology.2019.11.016_bib0011) 2007; 70 Tu (10.1016/j.urology.2019.11.016_bib0030) 2019 Gorin (10.1016/j.urology.2019.11.016_bib0004) 2019 Pepe (10.1016/j.urology.2019.11.016_bib0015) 2019; 39 Mortezavi (10.1016/j.urology.2019.11.016_bib0019) 2018; 200 Borkowetz (10.1016/j.urology.2019.11.016_bib0020) 2018; 121 Gross (10.1016/j.urology.2019.11.016_bib0022) 2019 Epstein (10.1016/j.urology.2019.11.016_bib0014) 2016; 40 Preisser (10.1016/j.urology.2019.11.016_bib0007) 2019 Albisinni (10.1016/j.urology.2019.11.016_bib0018) 2018; 28 (10.1016/j.urology.2019.11.016_bib0001) 2015 Pepe (10.1016/j.urology.2019.11.016_bib0003) 2018; 200 Pepe (10.1016/j.urology.2019.11.016_bib0012) 2014; 93 Aminsharifi (10.1016/j.urology.2019.11.016_bib0027) 2019; 110 |
| References_xml | – year: 2019 1 ident: bib0025 article-title: Extensive histological sampling following focal therapy of clinically significant prostate cancer with high intensity focused ultrasound publication-title: J Urol – year: 2019 ident: bib0030 article-title: Transperineal magnetic resonance imaging-targeted biopsy may perform better than transrectal route in the detection of clinically significant prostate cancer: systematic review and meta-analysis publication-title: Clin Genitourin Cancer – year: 2019 ident: bib0007 article-title: Performance of combined magnetic resonance imaging/ultrasound fusion-guided and systematic biopsy of the prostate in biopsy-naïve patients and patients with prior biopsies publication-title: Eur Urol Focus – volume: 110 start-page: 7 year: 2019 end-page: 13 ident: bib0027 article-title: Reduced Core Targeted (RCT) biopsy: Combining multiparametric magnetic resonance imaging - transrectal ultrasound fusion targeted biopsy with laterally-directed sextant biopsies - an alternative template for prostate fusion biopsy publication-title: Eur J Radiol – volume: 34 start-page: 1249 year: 2016 end-page: 1453 ident: bib0008 article-title: Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance? publication-title: World J Urol – volume: 122 start-page: 884 year: 2016 end-page: 892 ident: bib0005 article-title: Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies publication-title: Cancer – year: 2019 ident: bib0022 article-title: Healthcare Costs of Post-Prostate Biopsy Sepsis publication-title: Urology – volume: 195 start-page: 1403 year: 2016 end-page: 1408 ident: bib0002 article-title: The prevalence of clinically significant prostate cancer according to commonly used histological thresholds in men undergoing template prostate mapping bopsies publication-title: J Urol – volume: 2 start-page: 205 year: 2004 end-page: 213 ident: bib0013 article-title: Classification of surgical complications. A new proposal with evaluation in a Cohort of 6336 patients and results of survey publication-title: Ann Surg – volume: 40 start-page: 244 year: 2016 end-page: 252 ident: bib0014 article-title: The 2014 International society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new gradingsystem publication-title: Am J Surg Pathol – volume: 28 start-page: 18 year: 2018 end-page: 24 ident: bib0018 article-title: Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies? publication-title: Prog Urol – volume: 196 start-page: 1613 year: 2016 end-page: 1618 ident: bib0016 article-title: Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR publication-title: J Urol – volume: 201 start-page: 1121 year: 2019 end-page: 1126 ident: bib0028 article-title: Transperineal prostate biopsies using local anesthesia: experience with 1,287 patients. Prostate cancer detection rate, complications and patient tolerability publication-title: J Urol – volume: 200 start-page: 774 year: 2018 end-page: 778 ident: bib0003 article-title: Is it time to perform only MRI targeted biopsy? Our experience in 1032 men submitted to prostate biopsy publication-title: J Urol – year: 2015 ident: bib0001 article-title: Total Fair Price for Prostate Biopsy – volume: 200 start-page: 309 year: 2018 end-page: 318 ident: bib0019 article-title: Diagnostic accuracy of mpMRI and fusion-guided targeted biopsy evaluated by transperineal template saturation prostate biopsy for the detection and characterization of prostate cancer publication-title: J Urol – volume: 81 start-page: 1142 year: 2013 end-page: 1146 ident: bib0029 article-title: Morbidity following transperineal prostate biopsy in 3,000 patients submitted to 12 vs. 18 vs. more than 24 needle cores publication-title: Urology – volume: 200 start-page: 1235 year: 2018 end-page: 1240 ident: bib0026 article-title: Patient reported outcome measures for transperineal template prostate mapping biopsies in the PICTURE study publication-title: J Urol – volume: 2016 year: 2016 ident: bib0024 article-title: Assessment of the performance of magnetic resonance imaging/ultrasound fusion guided prostate biopsy against a combined targeted plus systematic biopsy approach using 24-core transperineal template saturation mapping prostate biopsy publication-title: Prostate Cancer – year: 2019 ident: bib0004 article-title: Transperineal prostate biopsy with cognitive magnetic resonance imaging/biplanar ultrasound fusion: description of technique and early results publication-title: World J Urol – volume: 21 start-page: 524 year: 2018 end-page: 532 ident: bib0006 article-title: Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research publication-title: Prostate Cancer Prostatic Dis – volume: 70 start-page: 1131 year: 2007 end-page: 1135 ident: bib0011 article-title: Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation publication-title: Urology – volume: 15 start-page: e33 year: 2017 end-page: e36 ident: bib0010 article-title: Transperineal versus transrectal MRI/TRUS fusion targeted biopsy: detection rate of clinically significant prostate cancer publication-title: Clin Genitourin Cancer – volume: 73 start-page: 30 year: 2009 end-page: 38 ident: bib0023 article-title: Bowel, urinary, and sexual problems among long-term prostate cancer survivors: a population- based study publication-title: Int J Radiat Oncol Biol Phys – volume: 196 start-page: 374 year: 2016 end-page: 381 ident: bib0017 article-title: The efficacy of multiparametric magnetic resonance imaging and magnetic resonance imaging targeted biopsy in risk classification for patients with prostate cancer on active surveillance publication-title: J Urol – volume: 121 start-page: 53 year: 2018 end-page: 60 ident: bib0020 article-title: Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy-naïve patients publication-title: BJU Int – volume: 64 start-page: 544 year: 2013 end-page: 552 ident: bib0009 article-title: Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group publication-title: Eur Urol – volume: 93 start-page: 189 year: 2014 end-page: 192 ident: bib0012 article-title: Detection rate of anterior prostate cancer in 226 patients submitted to initial and repeat transperineal biopsy publication-title: Urol Int – volume: 39 start-page: 1397 year: 2019 end-page: 1401 ident: bib0015 article-title: Prostate cancer diagnosis and management across twenty years of clinical practice: a single-center experience on 2,500 cases publication-title: Anticancer Res – volume: 73 start-page: 23 year: 2018 end-page: 30 ident: bib0021 article-title: Optimising the diagnosis of prostate cancer in the era of multiparametric magnetic resonance imaging: a cost-effectiveness analysis based on the prostate MR imaging study (PROMIS) publication-title: Eur Urol – year: 2015 ident: 10.1016/j.urology.2019.11.016_bib0001 – volume: 2016 year: 2016 ident: 10.1016/j.urology.2019.11.016_bib0024 article-title: Assessment of the performance of magnetic resonance imaging/ultrasound fusion guided prostate biopsy against a combined targeted plus systematic biopsy approach using 24-core transperineal template saturation mapping prostate biopsy publication-title: Prostate Cancer doi: 10.1155/2016/3794738 – year: 2019 ident: 10.1016/j.urology.2019.11.016_bib0025 article-title: Extensive histological sampling following focal therapy of clinically significant prostate cancer with high intensity focused ultrasound publication-title: J Urol doi: 10.1097/JU.0000000000000298 – volume: 196 start-page: 1613 year: 2016 ident: 10.1016/j.urology.2019.11.016_bib0016 article-title: Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR publication-title: J Urol doi: 10.1016/j.juro.2016.06.079 – volume: 196 start-page: 374 year: 2016 ident: 10.1016/j.urology.2019.11.016_bib0017 article-title: The efficacy of multiparametric magnetic resonance imaging and magnetic resonance imaging targeted biopsy in risk classification for patients with prostate cancer on active surveillance publication-title: J Urol doi: 10.1016/j.juro.2016.02.084 – volume: 200 start-page: 1235 year: 2018 ident: 10.1016/j.urology.2019.11.016_bib0026 article-title: Patient reported outcome measures for transperineal template prostate mapping biopsies in the PICTURE study publication-title: J Urol doi: 10.1016/j.juro.2018.06.033 – year: 2019 ident: 10.1016/j.urology.2019.11.016_bib0022 article-title: Healthcare Costs of Post-Prostate Biopsy Sepsis publication-title: Urology doi: 10.1016/j.urology.2019.06.011 – volume: 121 start-page: 53 year: 2018 ident: 10.1016/j.urology.2019.11.016_bib0020 article-title: Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy-naïve patients publication-title: BJU Int doi: 10.1111/bju.14017 – volume: 40 start-page: 244 year: 2016 ident: 10.1016/j.urology.2019.11.016_bib0014 article-title: The 2014 International society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new gradingsystem publication-title: Am J Surg Pathol doi: 10.1097/PAS.0000000000000530 – volume: 93 start-page: 189 year: 2014 ident: 10.1016/j.urology.2019.11.016_bib0012 article-title: Detection rate of anterior prostate cancer in 226 patients submitted to initial and repeat transperineal biopsy publication-title: Urol Int doi: 10.1159/000358494 – volume: 39 start-page: 1397 year: 2019 ident: 10.1016/j.urology.2019.11.016_bib0015 article-title: Prostate cancer diagnosis and management across twenty years of clinical practice: a single-center experience on 2,500 cases publication-title: Anticancer Res doi: 10.21873/anticanres.13254 – volume: 201 start-page: 1121 year: 2019 ident: 10.1016/j.urology.2019.11.016_bib0028 article-title: Transperineal prostate biopsies using local anesthesia: experience with 1,287 patients. Prostate cancer detection rate, complications and patient tolerability publication-title: J Urol doi: 10.1097/JU.0000000000000156 – year: 2019 ident: 10.1016/j.urology.2019.11.016_bib0030 article-title: Transperineal magnetic resonance imaging-targeted biopsy may perform better than transrectal route in the detection of clinically significant prostate cancer: systematic review and meta-analysis publication-title: Clin Genitourin Cancer doi: 10.1016/j.clgc.2019.05.006 – year: 2019 ident: 10.1016/j.urology.2019.11.016_bib0004 article-title: Transperineal prostate biopsy with cognitive magnetic resonance imaging/biplanar ultrasound fusion: description of technique and early results publication-title: World J Urol doi: 10.1007/s00345-019-02992-4 – volume: 28 start-page: 18 year: 2018 ident: 10.1016/j.urology.2019.11.016_bib0018 article-title: Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies? publication-title: Prog Urol doi: 10.1016/j.purol.2017.10.001 – volume: 64 start-page: 544 year: 2013 ident: 10.1016/j.urology.2019.11.016_bib0009 article-title: Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group publication-title: Eur Urol doi: 10.1016/j.eururo.2013.03.030 – volume: 2 start-page: 205 year: 2004 ident: 10.1016/j.urology.2019.11.016_bib0013 article-title: Classification of surgical complications. A new proposal with evaluation in a Cohort of 6336 patients and results of survey publication-title: Ann Surg doi: 10.1097/01.sla.0000133083.54934.ae – volume: 200 start-page: 309 year: 2018 ident: 10.1016/j.urology.2019.11.016_bib0019 article-title: Diagnostic accuracy of mpMRI and fusion-guided targeted biopsy evaluated by transperineal template saturation prostate biopsy for the detection and characterization of prostate cancer publication-title: J Urol doi: 10.1016/j.juro.2018.02.067 – volume: 195 start-page: 1403 year: 2016 ident: 10.1016/j.urology.2019.11.016_bib0002 article-title: The prevalence of clinically significant prostate cancer according to commonly used histological thresholds in men undergoing template prostate mapping bopsies publication-title: J Urol doi: 10.1016/j.juro.2015.11.047 – volume: 15 start-page: e33 year: 2017 ident: 10.1016/j.urology.2019.11.016_bib0010 article-title: Transperineal versus transrectal MRI/TRUS fusion targeted biopsy: detection rate of clinically significant prostate cancer publication-title: Clin Genitourin Cancer doi: 10.1016/j.clgc.2016.07.007 – volume: 73 start-page: 23 year: 2018 ident: 10.1016/j.urology.2019.11.016_bib0021 article-title: Optimising the diagnosis of prostate cancer in the era of multiparametric magnetic resonance imaging: a cost-effectiveness analysis based on the prostate MR imaging study (PROMIS) publication-title: Eur Urol doi: 10.1016/j.eururo.2017.08.018 – volume: 21 start-page: 524 year: 2018 ident: 10.1016/j.urology.2019.11.016_bib0006 article-title: Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research publication-title: Prostate Cancer Prostatic Dis doi: 10.1038/s41391-018-0056-7 – year: 2019 ident: 10.1016/j.urology.2019.11.016_bib0007 article-title: Performance of combined magnetic resonance imaging/ultrasound fusion-guided and systematic biopsy of the prostate in biopsy-naïve patients and patients with prior biopsies publication-title: Eur Urol Focus doi: 10.1016/j.euf.2019.06.015 – volume: 34 start-page: 1249 year: 2016 ident: 10.1016/j.urology.2019.11.016_bib0008 article-title: Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance? publication-title: World J Urol doi: 10.1007/s00345-015-1749-3 – volume: 122 start-page: 884 year: 2016 ident: 10.1016/j.urology.2019.11.016_bib0005 article-title: Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies publication-title: Cancer doi: 10.1002/cncr.29874 – volume: 81 start-page: 1142 year: 2013 ident: 10.1016/j.urology.2019.11.016_bib0029 article-title: Morbidity following transperineal prostate biopsy in 3,000 patients submitted to 12 vs. 18 vs. more than 24 needle cores publication-title: Urology doi: 10.1016/j.urology.2013.02.019 – volume: 73 start-page: 30 year: 2009 ident: 10.1016/j.urology.2019.11.016_bib0023 article-title: Bowel, urinary, and sexual problems among long-term prostate cancer survivors: a population- based study publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2008.04.004 – volume: 200 start-page: 774 year: 2018 ident: 10.1016/j.urology.2019.11.016_bib0003 article-title: Is it time to perform only MRI targeted biopsy? Our experience in 1032 men submitted to prostate biopsy publication-title: J Urol doi: 10.1016/j.juro.2018.04.061 – volume: 110 start-page: 7 year: 2019 ident: 10.1016/j.urology.2019.11.016_bib0027 article-title: Reduced Core Targeted (RCT) biopsy: Combining multiparametric magnetic resonance imaging - transrectal ultrasound fusion targeted biopsy with laterally-directed sextant biopsies - an alternative template for prostate fusion biopsy publication-title: Eur J Radiol doi: 10.1016/j.ejrad.2018.11.006 – volume: 70 start-page: 1131 year: 2007 ident: 10.1016/j.urology.2019.11.016_bib0011 article-title: Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation publication-title: Urology doi: 10.1016/j.urology.2007.07.068 |
| SSID | ssj0006667 |
| Score | 2.4515486 |
| Snippet | To evaluate the number of needle cores combined with multiparametric magnetic resonance imaging (mpMRI) findings needed to diagnose all clinically significant... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 133 |
| SubjectTerms | Aged Biopsy, Large-Core Needle - methods Biopsy, Large-Core Needle - standards Diagnostic Errors - prevention & control Humans Image-Guided Biopsy - methods Image-Guided Biopsy - standards Magnetic Resonance Imaging, Interventional - methods Male Middle Aged Neoplasm Grading Neoplasm Staging Outcome and Process Assessment, Health Care Prostate - diagnostic imaging Prostate - pathology Prostatic Neoplasms - diagnosis Prostatic Neoplasms - pathology |
| Title | How Many Cores Should be Obtained During Saturation Biopsy in the Era of Multiparametric Magnetic Resonance? Experience in 875 Patients Submitted to Repeat Prostate Biopsy |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0090429519310222 https://www.ncbi.nlm.nih.gov/pubmed/31758981 https://www.proquest.com/docview/2317586843 |
| Volume | 137 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIiEuiDfhpUGCU2QT2-vXCUFpVFVKqZRG6s1a25vgqthR4hzgwB9C4jcys-u13dKq0IsVrbU7tubLzjfjmVnG3rq5y8M89S20ldziSMEtIfPcSmPpuo4neabquKeHwf6cH5z4J4PB717W0rZO7ezHpXUlN9EqjqFeqUr2PzTbLooD-Bv1i1fUMF7_Scd0HtyUPtjvVug1j2Zf6bzqUSpHX1Ly-JFLftZViDNq36lV_amoVpvvJr1xby1UEoxKKxSUqEUd-3HRZUnVjSq6Ty055Dtv0muLTNPRBaEG_4UqkcP951tRE3tFLouknuIOR1RQglS2EdmnwfO1bv1E8QsqGDOJP4f2gd2LTRzhQormFvhYVTdalsWmMEn_8qzFJrLw5VLWmhBPKFK0qvphDfRh27wuHWsz9Tbn0kGREI4ttKD-uf1bd41pdmBH99VojHlz7y87oUMWp_ZWvy6l-MU2dXN1LvTlVpZ-RnJJLLJd5SHfYrdddEvoxAz7Z5dShK5g06NVP2VXMfb-UlFXcaGrfB3FeY7vs3uNswIfNfIesIEsH7I70yYd4xH7hQAEAiAoAIIGIKQSDABBAxA6AIJGAxQlIAABAQjVAi4AEAwAoQXgB-jgR5MRfmDgBy38oK5Aww8M_BqBj9l8sne8u281p39YGXfi2vK5GGd5mAV5nsXIsz3h-GiOZBylkZv7ofQWQizSPBzzXAgRZjwdi8gLAoleeZiNvSdsp6xK-YwBknhXeiLKAg_XDvLIW3i4P3HfWfhcOs6QcaOHJGta49MJLWeJyYE8TRr1JaQ-dJsTHB0yu5220r1hrpsQGCUnpvAZTXWCqLxu4hsDiQS3f_qmJ0pZbTeJS_w_CiLuDdlTjZX2WdStOHKe31TsC3a3-2u-ZDv1eitfIQev09cK-H8A1dPgxA |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=How+Many+Cores+Should+be+Obtained+During+Saturation+Biopsy+in+the+Era+of+Multiparametric+Magnetic+Resonance%3F+Experience+in+875+Patients+Submitted+to+Repeat+Prostate+Biopsy&rft.jtitle=Urology+%28Ridgewood%2C+N.J.%29&rft.au=Pepe%2C+Pietro&rft.au=Pennisi%2C+Michele&rft.au=Fraggetta%2C+Filippo&rft.date=2020-03-01&rft.pub=Elsevier+Inc&rft.issn=0090-4295&rft.volume=137&rft.spage=133&rft.epage=137&rft_id=info:doi/10.1016%2Fj.urology.2019.11.016&rft.externalDocID=S0090429519310222 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0090-4295&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0090-4295&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0090-4295&client=summon |